Pre-clinical development of CT-1119, a mesothelin targeting chimeric antigen receptor macrophage (CAR-M), for solid tumor immunotherapy

CT-1119 - CARISMA Therap

https://jitc.bmj.com/content/10/Suppl_2/A207

Nicholas Anderson; Michael Klichinsky; Kerri Ciccaglione; Stefano Pierini; Brinda Shah; Alison Worth; Rashid Gabbasov; Brett Menchel; Daniel Blumenthal; Sabrina DeLong; Sascha Abramson; Thomas Condamine

Oct 6, 2022